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Raf is one of the downstream effectors of Ras GTPases, and plays a key role in cell proliferation and 
differentiation through activation of MAPK. We have previously demonstrated that temporal induction of Raf in 
the epidermis of K14-Raf:ER mice results in development of psoriasis-like phenotype, including epidermal 
hyperplasia, lymphocyte and neutrophil infiltrates. It has been demonstrated that epidermal Stat3 activation was 
required for psoriasis development. Here, we investigated whether Stat3 signaling was involved in 
Raf-MAPK-dependent psoriasis-like lesions. Epidermal hyperplasia of K14-Raf:ER mice following topical 
tamoxifen (4OHT) application showed Stat3 activation in keratinocytes. We mated them with epidermis-specific 
Stat3 null mice (K5-Cre.Stat3f/f). Surprisingly, over-expression of Raf by 4OHT treatment in Stat3 deficient 
background (K14-Raf:ER;K5-Cre.Stat3f/f) demonstrated greatly attenuated epidermal hyperplasia or dermal cell 
infitrates, compared to K14-Raf:ER; Stat3f/wt mice. Also, up-regulation of psoriasis-associated cytokine profiles, 
including VEGF and IL-1 was decreased in the skin from K14-Raf:ER;K5-Cre.Stat3f/f upon 4OHT treatment. 
These results clearly indicated that Raf-MAPK-dependent psoriatic-skin development required Stat3 signaling in 
keratinocytes. Topical treatment of K14-Raf:ER mice skin with a Stat3 inhibitor STA-21 resulted in attenuation of 
epidermal hyperplasia upon 4OHT induction. Whereas K14-Raf:ER;IL17A-/- mice upon 4OHT treatment did not 
suppress Raf induced skin changes. Further analysis of the mechanistic crosstalk of these two important 
signalings in developing psoriasis is currently being undertaken. 
